X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AWH

Closed

Aspira Womens Health Inc

0.0784
+0.0514 (+190.37%)
Last Update: 16 May 2025 16:30:00
Yesterday: 0.027
Day's Range: 0.068 - 0.0829
Send
When Written:
 
0.366
Aspira Women's Health Inc. is a medical diagnostic company that specializes in developing and commercializing innovative diagnostic tests for women's health. The company's primary focus is on ovarian cancer diagnosis and risk assessment. Aspira's flagship product, OVA1, is a blood test that helps physicians assess the risk of ovarian cancer in women with pelvic masses. The company also offers a genetic test, called OVERA, which combines OVA1 with additional biomarkers to improve the accuracy of ovarian cancer risk assessment. Aspira is headquartered in Austin, Texas, and has operations in Europe and Asia. The company was founded in 2002 and went public in 2019.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X